ESPR

Esperion Therapeutics, Inc.

3.04

USD

ESPR Earnings Reports

Positive Surprise Ratio

ESPR beat 23 of 40 last estimates.

57%

Next Report

Date of Next Report

May 04, 2026

Estimate for Q1 26 (Revenue/ EPS)

$111.73M

$0.00

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

+71.90%

-100.00%

Esperion Therapeutics, Inc. earnings per share and revenue

On Jan 11, 2026, ESPR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.26 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 171.65 million, with a --% difference. The market reacted with a -8.51% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 6 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 111.73 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Esperion Therapeutics, Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Esperion Therapeutics, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Esperion Therapeutics, Inc.'s Q4 2025 earnings?

The stock price moved down -8.51%, changed from $3.88 before the earnings release to $3.55 the day after.

When is Esperion Therapeutics, Inc. expected to report next?

The next earning report is scheduled for May 04, 2026.

What are the forecasts for Esperion Therapeutics, Inc.'s next earnings report?

Based on 6 analysts, Esperion Therapeutics, Inc. is expected to report EPS of -- and revenue of $111.73M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.